Investor Presentation under Regulation 30 read with schedule III of SEBI (LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shanmuga Hospital Limited, a multi-specialty hospital based in Salem, Tamil Nadu, filed its Investor Presentation with BSE after recently listing on the BSE SME platform in 2025. The hospital has 150+ beds, 70+ doctors, and 245+ staff, with specialties including oncology, cardiology, and robotic surgery using a Da Vinci Xi system. FY25 financials show revenue of ₹47.85 crore (up from ₹43.04 crore in FY24), EBITDA of ₹8.17 crore, and PAT of ₹4.20 crore, though EBITDA margin fell from 20.58% to 17.56% and PAT margin dropped from 12.20% to 8.79%. Key growth plans include adding 50 inpatient beds, launching renal and liver transplant services, opening a nephro care center, and introducing the 'Shanmuga Health App.' The stock trades at ₹46.50 with a market cap of ₹63.30 crore and promoter holding of 72.11%.
The presentation provides a comprehensive business overview but shows margin compression in FY25 despite revenue growth, which investors should weigh against the company's expansion plans. Average bed occupancy of around 50% suggests room for utilization improvement, and the small market cap with recent SME listing means limited liquidity for shareholders.